English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Ruth de Jauregui
| Jun 7, 2017
Study indicates positive results using smaller, combination doses of blood pressure medication
Ruth de Jauregui
| Jun 7, 2017
Bristol-Myers Squibb, Novartis to study combination treatment for colorectal cancer
Ruth de Jauregui
| Jun 7, 2017
AstraZeneca sees positive results in treating BRCA-mutated breast cancer patients with Lynparza
Erianne Leatherman
| Jun 6, 2017
Novartis highlighting cancer care data at national, international forums
Erianne Leatherman
| Jun 6, 2017
Zykadia under consideration in Europe for expanded use to treat non-small cell lung cancer
Ruth de Jauregui
| Jun 4, 2017
Advaxis, Bristol-Myers Squibb to collaborate in metastatic cervical cancer study
Erianne Leatherman
| Jun 4, 2017
Revision to heart failure guideline released
Ruth de Jauregui
| Jun 4, 2017
National Institute of Health announces promising influenza study tool
Trending
+
Pharmaceuticals
Patient Daily
| Jun 30, 2025
PhRMA public affairs senior director on 340B program: 'PBMs took $140 billion in rebates and fees, driving up American medicine costs'
+
Pharmaceuticals
Patient Daily
| Jul 1, 2025
PhRMA chief public affairs officer on 340B drug pricing: ‘Lowering drug prices for U.S. patients starts by reining in middlemen’
+
Pharmaceuticals
Patient Daily
| Jun 25, 2025
Neurosurgeon at the University of California: ‘340B is being exploited for profit, not patient care’
« First
«
…
2
3
4
5
6
»
Last »